Literature DB >> 17621541

Pathogen-associated molecular pattern contamination as putative endogenous ligands of Toll-like receptors.

Min-Fu Tsan1, Baochong Gao.   

Abstract

Extensive work in recent years has suggested that a number of endogenous molecules, their derivatives or degradation products may be potent activators of the innate immune system capable of inducing pro-inflammatory cytokine production by the monocyte-macrophage system and the activation and maturation of dendritic cells. The cytokine-like effects of these endogenous molecules are mediated via Toll-like receptor (TLR) signal transduction pathways in a manner similar to pathogen-associated molecular patterns (PAMPs). However, recent evidence suggests that the reported cytokine effects of some of these putative endogenous ligands are in fact due to contaminating PAMPs. The reasons for the failure to recognize PAMP contaminants being responsible for the putative TLR ligands of these endogenous molecules include: (i) failure to use highly purified preparations free of PAMP contamination; (ii) failure to recognize the heat sensitivity of lipopolysaccharide (LPS); and (iii) failure to consider contaminant(s) other than LPS. Strategies are proposed to avoid future designation of PAMP contamination as putative endogenous ligands of TLRs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17621541     DOI: 10.1177/0968051907078604

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  45 in total

Review 1.  Toll-like receptors in ocular surface disease.

Authors:  Rachel L Redfern; Alison M McDermott
Journal:  Exp Eye Res       Date:  2010-03-24       Impact factor: 3.467

Review 2.  The danger model: questioning an unconvincing theory.

Authors:  Szczepan Józefowski
Journal:  Immunol Cell Biol       Date:  2015-07-28       Impact factor: 5.126

Review 3.  The critical role of toll-like receptors--From microbial recognition to autoimmunity: A comprehensive review.

Authors:  Maximiliano Javier Jiménez-Dalmaroni; M Eric Gerswhin; Iannis E Adamopoulos
Journal:  Autoimmun Rev       Date:  2015-08-20       Impact factor: 9.754

Review 4.  Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.

Authors:  Jamie Campbell; David Lowe; Matthew A Sleeman
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 5.  A calculated response: control of inflammation by the innate immune system.

Authors:  Gregory M Barton
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

6.  The majority of in vitro macrophage activation exhibited by extracts of some immune enhancing botanicals is due to bacterial lipoproteins and lipopolysaccharides.

Authors:  Nirmal D Pugh; Hemlata Tamta; Premalatha Balachandran; Xiangmei Wu; J'Lynn Howell; Franck E Dayan; David S Pasco
Journal:  Int Immunopharmacol       Date:  2008-04-07       Impact factor: 4.932

Review 7.  Innate and adaptive immune responses to cell death.

Authors:  Kenneth L Rock; Jiann-Jyh Lai; Hajime Kono
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

8.  Expression and immune effect of toll-like receptor 4 in human trophoblast cells.

Authors:  Feitao Deng; Fang Han; Chaoying Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

9.  Toll-like receptors as targets in chronic liver diseases.

Authors:  A Mencin; J Kluwe; R F Schwabe
Journal:  Gut       Date:  2009-05       Impact factor: 23.059

Review 10.  Toll-like receptors in kidney disease.

Authors:  Kelly D Smith
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-05       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.